Insulin in oral immune 'tolerance': A one-amino acid change in the B chain makes the difference

Journal of Immunology

Volumn 163, Issue 4, 1999, Pages 1833-1838

  Homann, Dirk ^a   Dyrberg, Thomas ^b   Petersen, Jacob ^b   Oldstone, Michael B A ^a   Von Herrath, Matthias G ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; NUCLEOPROTEIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CYTOTOXICITY TEST; FEMALE; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ADMINISTRATION, ORAL; ADOPTIVE TRANSFER; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; IMMUNE TOLERANCE; INSULIN; LYMPHOCYTE TRANSFUSION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MOLECULAR SEQUENCE DATA; NUCLEOPROTEINS; ORGAN SPECIFICITY; PEPTIDE FRAGMENTS; SPLEEN; SWINE;

EID: 0033566743     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Atkinson, M. A., and N. K. Maclaren. 1994. The pathogenesis of insulin-dependent diabetes mellitus. N. Engl. J. Med. 331:1428.
2. Weiner, H. L. 1997. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol. Today 18:335.
3. von Herrath, M. G. 1997. Bystander suppression induced by oral tolerance. Res. Immunol. 148:541.
4. Bach, J.-F., and D. Mathis. 1997. The NOD mouse. Res. Immunol. 148:281.
5. von Herrath, M. G., J. Dockter, and M. B. A. Oldstone. 1994. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity 1:231.
6. Oldstone, M. B. A., M. Nerenberg, P. Southern, J. Price, and H. Lewicki. 1991. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 65:319.
7. von Herrath, M. G., T. Dyrberg, and M. B. A. Oldstone. 1996. Oral insulin treatment suppresses virus-induced antigen-specific destruction of β cells and prevents autoimmune diabetes in transgenic mice. J. Clin. Invest 98:1324.
8. Zang, J. A., L. Davidson, G. Eisenbarth, and H. Weiner. 1991. Suppression of diabetes in NOD mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. USA 88:10252.
9. Benson, J. M., and C. C. Whitacre. 1997. The role of clonal deletion and anergy in oral tolerance. Res. Immunol. 148:533.
10. Maron, R., V. Palanivel, H. L. Weiner, and D. A. Harn. 1998. Oral administration of schistosome egg antigen and insulin B-chain generates and enhances Th2-type responses in NOD mice. Clin. Immunol. Immunopathol. 87:85.
11. Homann, D., A. Tishon, D. P. Berger, W. O. Weigle, M. G. von Herrath, and M. B. Oldstone. 1998. Evidence for an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from μMT/μMT mice. J. Virol. 72:9208.
12. Sai, P., and A. S. Rivereau. 1996. Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments: comparative efficiency of human insulin and two bacterial antigens, lipopolysaccharide from Escherichia coli and glycoprotein extract from Klebsiella pneumoniae. Diabetes Metab. 22:341.
13. Jackson, R. A., J. S. Soeldner, and G. S. Eisenbarth. 1988. Predicting insulin-dependent diabetes. Lancet 10:627.
14. Keller, R. J., G. S. Eisenbarth, and R. A. Jackson. 1993. Insulin prophylaxis in individuals at high risk for type I diabetes. Lancet 341:927.
15. Hancock, W. W., M. Polanski, J. Zhang, N. Blogg, and H. L. Weiner. 1995. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-β, and proslaglandin-E. Am. J. Pathol. 147:1193.
16. Hutchings, P. R., and A. Cooke. 1995. Comparative study of the protective effect afforded by intravenous administration of bovine or ovine insulin to young NOD mice. Diabetes 44:906.
17. Muir, A., A. Peck, M. Clare-Salzler, Y. H. Song, J. Cornelius, R. Luchetta, J. Krischer, and N. Maclaren. 1995. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-γ transcription. J. Clin. Invest. 95:628.
18. Daniel, D., and D. R. Wegmann. 1996. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc. Natl. Acad. Sci. USA 93:956.
19. Smilek, D. E., D. C. Wraith, S. Hodgkinson, S. Dwivedy, L. Steinman, and H. O. McDevitt. 1991. A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 88:9633.
20. Javed, N. H., I. E. Gienapp, K. L. Cox, and C. C. Whitacre. 1995. Exquisite peptide specificity of oral tolerance in experimental autoimmune encephalomyelitis. J. Immunol. 155:1599.
21. Harrison, L. C., M. Dempsey-Collier, D. R. Kramer, and K. Takahashi. 1996. Aerosol insulin induces regulatory CD8 γδ T cells that prevent murine insulin-dependent diabetes. J. Exp. Med. 184:2167.
22. Ploix, C., I. Bergerot, N. Fabien, S. Perche, V. Moulin, and C. Thivolet. 1998. Protection against autoimmune diabetes with oral insulin is associated with the presence of IL-4 type 2 T-cells in the pancreas and pancreatic lymph nodes. Diabetes 47:39.
23. + T cells that suppress adoptive transfer of diabetes. J. Autoimmunity 7:655.
24. Karounos, D. G., J. S. Bryson, and D. A. Cohen. 1997. Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice. J. Clin. Invest. 100:1344.
25. Ma, S.-W., D.-L. Zhao, Z.-Q. Yin, R. Mukherjee, B. Singh, H.-Y. Qin, C. R. Stiller, and A. M. Jevnikar. 1997. Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance. Nat. Med. 3:793.
26. Tian, J., M. A. Atkinson, M. Clare-Salzler, A. Herschenfeld, T. Forsthuber, P. V. Lehmann, and D. L. Kaufman. 1996. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J. Exp. Med. 183:1561.